MindMed (MNMD) stock is expanding the psychedelic’s market for investors
MindMed is a clinical stage psychedelic medicine biotech company. This biotech company specifically focuses on the discovery and development of innovative therapies and medicines that target psychological and mental illness like an addiction. The pipeline of the company includes the development of psychedelic substances which include 18-MC, Dimethyltryptamine (DMT), MDMA, Lysergic acid Diethylamide, Psilobycin and […]
Is this what caused MindMed (OTC: MMEDF) stock to decline during the last trading day of the previous week
MindMed (OTC: MMEDF), the stock closed down -0.30% from the previous close to $3.63 Friday, despite no news on the day.MindMed is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company has a market capitalization of 1,200,150,931, and it has traded […]
Psychedelic Stocks: Consider Investing In These 3 Stocks
Back in 2014 when investors started trading marijuana stocks Wall Street dubbed it as just the flavour of the year. But since then, psychedelic stocks have seen billions of dollars be invested in them and hundreds of companies revolving them have launched themselves. This is also due to the scientific research which now supports the […]